Vicarious Surgical Inc. Files 8-K: Officer/Director Changes & More
Ticker: RBOTW · Form: 8-K · Filed: Dec 3, 2025 · CIK: 1812173
| Field | Detail |
|---|---|
| Company | Vicarious Surgical Inc. (RBOTW) |
| Form Type | 8-K |
| Filed Date | Dec 3, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.0001, $11.50 |
| Sentiment | neutral |
Sentiment: neutral
Topics: officer-changes, director-changes, regulation-fd, filing
Related Tickers: RBOT
TL;DR
Vicarious Surgical (RBOT) filed an 8-K on 12/3/25 for 12/1/25 events: director/officer changes, comp plans, and Reg FD disclosures.
AI Summary
Vicarious Surgical Inc. filed an 8-K on December 3, 2025, reporting events as of December 1, 2025. The filing covers the departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements. It also includes Regulation FD disclosures and financial statements/exhibits.
Why It Matters
This filing indicates potential shifts in the company's leadership and governance structure, which could impact strategic direction and investor confidence.
Risk Assessment
Risk Level: medium — Changes in key personnel and compensatory arrangements can signal internal shifts that may affect future performance.
Key Players & Entities
- Vicarious Surgical Inc. (company) — Registrant
- 0001812173 (company) — Central Index Key
- December 1, 2025 (date) — Earliest event reported
- December 3, 2025 (date) — Filing date
FAQ
What specific officer or director positions were affected by the events reported on December 1, 2025?
The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" but does not specify names or positions within the provided text.
Are there any details regarding new compensatory arrangements for officers or directors?
The filing lists "Compensatory Arrangements of Certain Officers" as an item, but specific details are not included in the provided text.
What is the significance of the Regulation FD Disclosure mentioned in the filing?
Regulation FD disclosures ensure that material non-public information is broadly disseminated to the public, preventing selective disclosure.
What types of financial statements and exhibits are included with this 8-K filing?
The filing states "Financial Statements and Exhibits" are included, but the specific content of these exhibits is not detailed in the provided text.
What was Vicarious Surgical Inc.'s former company name?
Vicarious Surgical Inc.'s former company name was D8 Holdings Corp., with a date of name change on May 14, 2020.
Filing Stats: 707 words · 3 min read · ~2 pages · Grade level 10.9 · Accepted 2025-12-03 07:01:19
Key Financial Figures
- $0.0001 — tered Class A common stock, par value $0.0001 per share RBOT The New York Stock E
- $11.50 — mon stock, each at an exercise price of $11.50 per share RBOT WS The New York Stoc
Filing Documents
- ea0268207-8k_vicarious.htm (8-K) — 35KB
- ea026820701ex99-1_vicarious.htm (EX-99.1) — 11KB
- 0001213900-25-117558.txt ( ) — 258KB
- rbot-20251201.xsd (EX-101.SCH) — 4KB
- rbot-20251201_def.xml (EX-101.DEF) — 26KB
- rbot-20251201_lab.xml (EX-101.LAB) — 36KB
- rbot-20251201_pre.xml (EX-101.PRE) — 25KB
- ea0268207-8k_vicarious_htm.xml (XML) — 6KB
02 Departure of Directors or Certain
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. On December 1, 2025 (the "Effective Date"), Beverly Huss and Randy Clark each resigned as a member of the Board of Directors (the "Board") of Vicarious Surgical Inc. (the "Company"), effective as of the Effective Date. Ms. Huss's and Mr. Clark's resignations were tendered in connection with a decision by the Board to reduce its size, and did not result from any disagreement regarding the Company's operations, policies or practices. In connection with Ms. Huss's and Mr. Clark's resignations, the Board reduced its size from nine members to seven as of the Effective Date. To address the resulting committee vacancies, Joseph Doherty was appointed as a member of the Audit Committee of the Board, Fuad Ahmad was appointed as a member of the Compensation Committee of the Board (the "Compensation Committee"), and Victoria Carr-Brendel was appointed as Chair of the Compensation Committee, in each case effective as of the Effective Date.
01. Regulation FD Disclosure
Item 7.01. Regulation FD Disclosure. On December 3, 2025, the Company issued a press release announcing updated guidance on the Company's cash burn for 2025 and the committee changes described in Item 5.02. A copy of the press release is furnished as Exhibit 99.1 hereto. The information in this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated December 3, 2025 104 Cover Page Interactive Data File (embedded within the Inline XBRL document) 1
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. VICARIOUS SURGICAL INC. By: /s/ Stephen From Name: Stephen From Title: Chief Executive Officer Date: December 3, 2025 2